Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics

The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2 infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of candidates was evaluated, with mRNA-based vaccines emerging as leaders due to how quickly they were available for emergency use w...

Descripción completa

Detalles Bibliográficos
Autores principales: Semple, Sean C., Leone, Robert, Barbosa, Christopher J., Tam, Ying K., Lin, Paulo J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876479/
https://www.ncbi.nlm.nih.gov/pubmed/35214130
http://dx.doi.org/10.3390/pharmaceutics14020398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876479/
https://www.ncbi.nlm.nih.gov/pubmed/35214130
http://dx.doi.org/10.3390/pharmaceutics14020398

Ejemplares similares